Q2 2018 Holdings
Filed 2018-08-14 | 35 holdings | $116.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-08-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $30.7M | 364,776 | 26.4% |
| Codexis Inc(CDXS) | COM | 192005106 | $29.2M | 2,025,000 | 25.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $26.6M | 270,000 | 22.8% |
| Biolife Solutions Inc(BLFS)A | COM NEW | 09062W204 | $11.4M | 1,000,000 | 9.8% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $10.8M | 70,000 | 9.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.7M | 207,500 | 4.1% |
| Caredx Inc(CDNA) | COM | 14167L103 | $2.4M | 200,000 | 2.1% |
| Foundation Medicine Inc | COM | 350465100 | $93.6K | 685,000 | 0.1% |
| Loxo Oncology Inc | COM | 548862101 | $62.5K | 360,000 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $40.3K | 635,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $39.1K | 250,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $38.7K | 780,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $38.3K | 463,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $31.4K | 200,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $29.5K | 2,600,000 | 0.0% |
| Magenta Therapeutics IncA | COM | 55910K108 | $27.5K | 2,035,818 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $22.2K | 1,135,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $21.7K | 480,000 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $21.7K | 3,400,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $20.0K | 71,500 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $19.9K | 1,400,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $17.2K | 450,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $12.9K | 220,000 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $11.6K | 550,000 | 0.0% |
| Orasure Technologies Inc(OSUR) | COM | 68554V108 | $10.5K | 640,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $10.0K | 220,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $6.4K | 178,333 | 0.0% |
| Neogen Corp(NEOG) | COM | 640491106 | $5.2K | 65,000 | 0.0% |
| Neon Therapeutics IncA | COM | 64050Y100 | $4.3K | 338,345 | 0.0% |
| Loxo Oncology IncPut | COM | 548862101 | $3.5K | 20,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $3.1K | 135,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $2.9K | 375,000 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $2.3K | 115,000 | 0.0% |
| Global Blood Therapeutics inPut | COM | 37890U108 | $2.3K | 50,000 | 0.0% |
| Blueprint Medicines Corp(2L9)Call | COM | 09627Y109 | $635 | 10,000 | 0.0% |